FDA Inspection
Eric J. Lawitz, M.D.Eric J. Lawitz, M.D. – FDA Inspection, Aug 24, 2012
Record Details
This FDA Inspection record concerns Eric J. Lawitz, M.D., with an inspection on August 24, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Eric J. Lawitz, M.D.
- Inspection Date
- August 24, 2012
- Product Type
- Drugs
View Company Profile
ID · c9ddd703-4ee6-4317-9094-a680af09a7f3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 797771
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eric J. Lawitz, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 19, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 3, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 24, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 14, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Eric J. Lawitz, M.D.
- FDA Inspection 1227747 - 2024-01-19
- FDA Inspection 1006414 - 2017-03-03
- FDA Inspection 837585 - 2013-06-24
- FDA Inspection 662046 - 2010-05-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.